⌘K

Login Start Free

Home/Filings/4/0001493152-19-000042

4//SEC Filing

Yeaton Howard 4

Accession 0001493152-19-000042

CIK 0001321834other

View on SEC.gov Company Profile

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 5:00 PM ET

Size

4.4 KB

Accession

0001493152-19-000042

Insider Transaction Report

Form 4

Period: 2018-12-28

Akers Biosciences, Inc.AKER

CEO, CFO

Transactions

Award
Common Stock
2018-12-28$1.27/sh+7,500$9,525→ 7,500 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Akers Biosciences, Inc.

CIK 0001321834

Entity typeother

Related Parties

1

filerCIK 0001341910

Filing Metadata

Form type: 4
Filed: Jan 1, 7:00 PM ET
Accepted: Jan 2, 5:00 PM ET
Size: 4.4 KB

View on SEC.gov